Tiotropium bromide

Nature Reviews Drug Discovery

Volumn 3, Issue 8, 2004, Pages 643-644

  Mundy, Cynthia ^a   Kirkpatrick, Peter ^b  

^a Decision Resources Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR; PLACEBO; ROFLUMILAST; SALMETEROL; TIOTROPIUM BROMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE DERIVATIVE; TIOTROPIUM;

AIR POLLUTION; AIRWAY OBSTRUCTION; ASTHMA; BINDING AFFINITY; BRONCHOSPASM; CAUSE OF DEATH; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRY POWDER; DYSPNEA; EARLY DIAGNOSIS; EMPHYSEMA; HEALTH CARE COST; HUMAN; INCIDENCE; LUNG FUNCTION; MONOTHERAPY; NAUSEA; NOTE; POWDER INHALER; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; STRUCTURE ANALYSIS; ARTICLE; STRUCTURE ACTIVITY RELATION;

HUMANS; IPRATROPIUM; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 4344607825     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1472     Document Type: Note

References (10)

1. Barnes, P. J. Chronic obstructive pulmonary disease. N. Engl. J. Med. 343, 269-280 (2000).
2. Lopez, A. D. & Murray, C. C. J. L. The global burden of disease, 1990-2020. Nature Med. 4, 1241-1243 (1998).
3. Barnes, P. J. New treatments for COPD. Nature Rev. Drug Discov. 1, 437-446 (2002).
4. Disse, B. et al. Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci. 52, 537-544 (1993).
5. Barnes, P. J. et al. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci. 56, 853-859 (1995).
6. Casaburi, R. et al. A long-term evaluation of once-daily inhaled tiotropium bromide in chronic obstructive pulmonary disease. Eur. Respir. J. 19, 217-224 (2002).
7. Vincken, W. et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur. Respir. J. 19, 209-216 (2002).
8. Donohue, J. F. et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 122, 47-55 (2002).
9. Brusasco, V. et al. Heath outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax 58, 399-404 (2003).
10. FDA drug approvals list [online] (cited 10 June 2004) http://www.fda.gov/cder/foi/label/2004/21395_spiriva_lbl.pdf (2004).